Skip to content

Assessment of Postoperative Changes in Cardiac Volume and Function in Acute Myocardial Infarction Patients Undergoing Revascularization Surgery by Artificial Intelligence Echocardiography

Assessment of Postoperative Changes in Cardiac Volume and Function in Acute Myocardial Infarction Patients Undergoing Revascularization Surgery by Artificial Intelligence Echocardiography

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080455
Enrollment
Unknown
Registered
2024-01-30
Start date
2024-01-31
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

LVR Group/ NLVR Group:None

Sponsors

The First People's Hospital of Foshan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ?Meets the diagnostic criteria for AMI (including STEMI and NSTEMI) in the 2019 Emergency Rapid Diagnosis and Treatment Guidelines for Acute Coronary Syndrome: cTn>99th upper limit of normal reference value (ULN) Or CK-MB>99th ULN, accompanied by one or more of the following conditions: persistent ischemic chest pain, the electrocardiogram shows an upward elevation of the ST segment arch or a newly developed ST segment depression, or a low, flat, and inverted T wave, Echocardiography shows segmental abnormal ventricular wall activity, or Coronary angiography abnormalities. ?The patient is = 75 years old, and the distal blood flow of the infarcted artery after PCI reaches TIMI3 level. ?MCE examination can fully and clearly display the myocardial perfusion in each segment of the left ventricular wall. ?Good image quality, automatic strain imaging technology and cardiac dynamic model technology can successfully obtain corresponding parameters. ?Voluntary signing of informed consent form.

Exclusion criteria

Exclusion criteria: Patients with old myocardial infarction, severe arrhythmia and moderate to severe valve disease, congenital heart disease, cardiomyopathy (dilated cardiomyopathy, hypertrophic cardiomyopathy, cardiomyopathy caused by metabolic diseases, etc.), myocarditis, allergies to ultrasound enhancers, and poor image quality.

Design outcomes

Primary

MeasureTime frame
Ultrasound measurement indicators;

Countries

China

Contacts

Public ContactWang Fei

The First People's Hospital of Foshan

doctor_wf@126.com+86 180 3886 3993

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026